Parisi Gray Wealth Management Sells 3,005 Shares of Danaher Corporation $DHR

Key Points

• Parisi Gray Wealth Management has reduced its stake in Danaher Corporation by 19.1%, selling 3,005 shares, leaving them with a total of 12,763 shares valued at $2,521,000.
• Danaher reported a quarterly earnings per share of $1.80, exceeding analysts' expectations of $1.64, with revenues reaching $5.94 billion, which is 3.4% higher year-over-year.
• The company announced a $0.32 quarterly dividend to be paid on October 31st, which translates to an annualized yield of 0.7%, while insider ownership stands at 11.20% of the stock.

Parisi Gray Wealth Management reduced its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 19.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,763 shares of the conglomerate's stock after selling 3,005 shares during the period. Parisi Gray Wealth Management's holdings in Danaher were worth $2,521,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in DHR. Heck Capital Advisors LLC purchased a new stake in Danaher during the fourth quarter worth about $27,000. GHP Investment Advisors Inc. increased its holdings in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after buying an additional 99 shares during the last quarter. Sierra Ocean LLC increased its holdings in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after buying an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC purchased a new stake in Danaher during the first quarter worth about $31,000. Finally, Dunhill Financial LLC increased its holdings in Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after buying an additional 67 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 2,778 shares of the company's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 11.20% of the company's stock.

Danaher Price Performance

DHR stock opened at $190.07 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90. The stock has a market cap of $136.10 billion, a PE ratio of 40.44, a P/E/G ratio of 2.65 and a beta of 0.75. The firm has a 50 day simple moving average of $201.21 and a two-hundred day simple moving average of $198.78.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business's quarterly revenue was up 3.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Friday, September 26th. Danaher's payout ratio is presently 27.23%.

Analyst Ratings Changes

DHR has been the subject of several recent research reports. Robert W. Baird lifted their target price on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research note on Friday, July 18th. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a research note on Tuesday, September 2nd. Barclays reiterated an "overweight" rating and issued a $225.00 target price (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Wells Fargo & Company reduced their price objective on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 23rd. Finally, UBS Group reduced their price objective on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a research note on Wednesday, July 23rd. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $246.35.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.